Ozempic and Other GLP-1 Drugs in the Litigation While Ozempic remains the most prominent name in the lawsuits, other GLP-1 drugs face similar legal action: Wegovy (semaglutide) Same active ingredient as Ozempic, marketed specifically for chronic weight management Rybelsus (oral semaglutide) Pill form of semaglutide Mounjaro (tirzepatide) Newer GLP-1 drug with similar mechanism Trulicity (dulaglutide) Another injectable GLP-1 receptor agonist Patients prescribed any of these medications for either diabetes treatment or weight loss may qualify to file an Ozempic lawsuit if they developed gastroparesis, intestinal blockage, vision loss, or other serious adverse effects
Brand name semaglutide pen (Ozempic or Wegovy): Compounded syringe: General instructions on drawing up any medication and injecting subcutaneously
How Does Liposomal Glutathione Support Healthy Ageing for an Improved Quality of Life
The SmPCs for these medications advise considering dose reduction of insulin or sulfonylureas when initiating weight loss injections to minimise this risk
If Trump continues down this path, he will bring Washingtons long imperial tradition in Latin America back to the very place it began in 1898
Brain L, Jellinek EH, Ball K